Eli Lilly and Company plans to invest $6.5 billion to build a manufacturing facility at Generation Park in Houston, Texas.

Pharma giant Eli Lilly confirmed plans for the plant in Houston where an oral GLP-1 weight loss drug could be made, creating ...

Eli Lilly and Co. (NYSE: LLY) confirmed Sept. 23 that the Bayou City will be part of its domestic manufacturing push. David ...

Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ ...

The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing ...

Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing ...

Eli Lilly has revealed the location of the second of its four large-scale manufacturing facilities that it plans to build in ...

Lilly expects to open 615 high-wage roles in Texas in connection with its new facility, plus around 4,000 construction roles.

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

Eli Lilly has announced its plans to build the second of four US manufacturing facilities at Generation Park in Houston, ...

Governor Greg Abbott will speak in Houston Tuesday with Eli Lilly leaders to announce a major economic development initiative through Texas’ JETI and Enterprise Fund programs.

The Houston facility has been selected as one that will make orforglipron, Lilly's new oral GLP-1 agonist for weight-loss, ...